Because the CVInsight® System measures a patient’s global cardiovascular response in real-time, it is applicable for use in multiple conditions and disease states. Those include:
- Heart disease, including Heart Failure
- Sleep-disturbed breathing
Hemodialysis is the initial CVInsight® commercial market, targeted because of physician enthusiasm for a solution to help alert to patient decompensation. The “Contact” (Forehead Sensor) CVInsight® product is currently used in this market since it is an FDA-cleared device. Additionally, the product is cleared for multiple sites of care including hospitals, medical facilities, ambulatory, sub-acute, and sleep studies. The “Non-Contact” product should add sites of care, including telemedicine.